Bloodstream Infection Testing Market: Top Geographies and Market Highlights
Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMerieux SA, Bruker Corp., Danaher Corp., and F. Hoffmann La Roche Ltd are among the key vendors discussed in the research report
The bloodstream infection testing market is set to post an incremental growth of $ 3.56 bn, accelerating at a CAGR of about 8% during the forecast period. Our market investigates the key markets and the factors that are likely to boost growth along with challenges that need to be surpassed to promote success in the market. The report also provides an analysis of key segments and offers competitive benchmarking of the key market players and their product portfolios.
For market insights and a better understanding of the quality of our research:
Request for our FREE Sample Report
Bloodstream Infection Testing Market: North America to lead market growth during the forecast period
Bloodstream Infection Testing Market: Competitive Landscape
Some of the leading vendors in this market are Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMerieux SA, Bruker Corp., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.. The market is fragmented and the growth of the players in this market is dependent on several factors such as prevalent market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. For more insights on this market: Download a Free Sample Report
Browse through some of other related market research reports for more insights:
The report provides insights into the following FAQs:
Market Segmentation by Technology
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Bloodstream Infection Testing Market Growth Analysis | Trends, Drivers and Vendor Forecasts for 2021-2025
Technavio has been monitoring the bloodstream infection testing market and it is expected to grow by $ 3.56 bn, accelerating at a CAGR of almost 8.01% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking
Bloodstream Infection Testing Market: Receive Free Sample Report
Bloodstream Infection Testing Market: Key Trends to impact market growth
Growth by the conventional testing segment will be significant during the forecast period. The low cost, and therefore the high availability of conventional testing standards are reasons for the larger share of the segment. North America has been exhibiting a significant growth rate for bloodstream infection testing market vendors. Factors such as high awareness of blood safety and transfusion-transmitted infections are accelerating the bloodstream infection testing market growth in the region. However, market share growth in North America will be slower than that in Asia during the forecast period. This research report provides a detailed impact analysis of all the trends that are likely to influence the growth of the market in focus.
Bloodstream Infection Testing Market: Top Drivers to Boost Demand
Increase in hospital visits is one of the primary factors driving the growth of the bloodstream infection testing market. The prevalence of chronic diseases is increasing globally, which in turn, is raising the number of patient visits to hospitals. Hospitals are a prominent source of infection, resulting in a rise in morbidity and mortality in hospitalized patients. Intensive care units are often the epicenter of these infections, mainly because they are vulnerable to infections through multiple invasive, therapeutic, and diagnostic procedures. The report provides a detailed study of all the factors that are likely to boost the market. This analysis will enable clients to leverage growth opportunities to their advantage and set their business ont he path to future growth.
Vendor Analysis: Abbott Laboratories, Accelerate Diagnostics Inc. and Becton, Dickinson and Co. are key growth contributors
The market is fragmented. The research report provides insights into the top market player and their product portfolio along with a pipeline analysis of upcoming developments and growth opportunities. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMerieux SA, Bruker Corp., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the major market participants.
For more insights on this market: Download a Free Sample Report
Bloodstream Infection Testing Market: Key Highlights of the Report for 2021-2025